Posted In: Cancer Research
Eric Lefkofsky is the founder and CEO of Tempus, one of Chicago’s top ten tech startups. Tempus is focused on building the world’s largest library of molecular and clinical data along with an operating system that it hopes will bridge the disconnect between collected data and cancer patient treatment and make that information accessible and useful to physicians and other healthcare workers. Ultimately, he hopes this would lead to more personalized cancer care and improved patient outcomes. Started in 2015 by Lefkofsky and his longtime business partner, Tempus has since grown to a 200-person company that has recently raised $70 million in venture capital, the largest amount of funding in the third quarter of 2017.